Skip to main content
International Journal of Clinical and Experimental Pathology logoLink to International Journal of Clinical and Experimental Pathology
. 2019 Nov 1;12(11):4167–4170.

Terminal deoxynucleotidyl transferase negative T-cell lymphoblastic lymphoma from heterotopic Warthin’s tumor in cervical lymph nodes: a case report and review of literature

Xubo Pan 1,*, Shengqiang Yu 2,*, Lisha Che 1, Junqing Xu 3, Huihui Zhou 1
PMCID: PMC6949790  PMID: 31933816

Abstract

Collision of lymphoma and Warthin’s tumor (WT) is extremely uncommon, especially T-cell lymphoma. Here we present a 69-year-old woman who had terminal deoxynucleotidyl transferase (TDT) negative T-cell lymphoblastic lymphoma (T-LBL) from heterotopic Warthin’s tumor in cervical lymph nodes, in which only cervical lymph nodes enlarged initially and quickly progressed to systemic lesions.

Keywords: Heterotopic Warthin’s tumor, T-cell lymphoblastic lymphoma, terminal deoxynucleotidyl transferase negative, collision tumor, cervical lymph nodes

Introduction

Warthin’s tumor (WT), also known as papillary cystadenoma lymphomatosum, a common benign neoplasm of salivary gland, exclusively occurs in the parotid gland or ectopic salivary gland in periparotid lymph nodes (LN). Tumors are typically composed of proliferative eosinophilic epithelium and lymphoid stroma. The epithelium consists of two layers of cells, of which the eosinophilic lumen cells are high columnar with uniform palisade-like nuclei, and there are often acrosomal secretory vesicles on the cell surface. The deep part is a layer of smaller flat or cuboid basal cells without obvious atypical cells or mitosis. The stroma comprises lymphoid tissue with varying degrees of reactivity, usually accompanied by obvious germinal centers [1,2].

Approximately 1% of WT undergo malignant transformation, which can occur in either the epithelial or lymphoid components [1]. Uncommonly, the malignant lymphoma occurs in WT lymphoid stroma and the majority are B-cell lymphoma and Hodgkin’s lymphoma [3-23]. There are only two English reports about the co-existence of WT and T-cell lymphoma in parotid gland [24,25] and as far as we know, this is the first report in the English literature describing TDT negative T-cell lymphoblastic lymphoma (T-LBL) in neck heterotopic Warthin’s tumor.

Case report

A 69-year-old woman was admitted to hospital with a painless rapidly growing mass on the left neck.

One month ago, an oval mass about the size of a quail egg was unexpectedly found on the left side of her neck, and grew to egg size. She denied smoking and malignant tumor history and had no fever, night sweats, or weight loss (B symptoms). By physical examination, a non-tender nodule of about 6.6*3.5 cm could be palpated on the left side of the neck with a smooth surface and tough texture. No obvious abnormality was found in hemogram indexes. PET-CT showed multiple enlarged LN shadows in bilateral cervical region II, left cervical region III and V accompanied by increased FDC metabolism and SUVmax was 9.1. These were malignant lesions, but there were no obvious malignant symptoms in other parts of the body. The patient underwent surgical resection of two nodules from left neck. The specimen received in formalin consisted of two gray-red soft nodules measured 3*2*1.5 cm and 5*3*2 cm. The cut surface was translucent, slightly leafy with clear boundary. Microscopically, tumors had a thin envelope and were composed of cysts covered by typical WT epithelial and diffuse lymphoid components (Figure 1A). The epithelium was eosinophilic two-layer architecture without heterotypic cells. There were numerous large cells in the diffuse lymphoid matrix with focal or sheet distribution, which had abundant cytoplasm, irregular nuclei, finely dispersed chromatin, and mitotic figures visible (Figure 1B). Immunohistochemical examination showed that the atypical lymphocytes expressed strong positivity for CD5, CD7, CD34, partly CD4 and were negative for TdT, CD8 and PAX5. The Ki-67 proliferation fraction was approximately 85% (Figure 1C-F). A diagnosis of T-LBL with coexistent WT was based on the findings described above. Unfortunately, the patient was discharged without any treatment. Two months later, the patient suffered from fatigue and loss of appetite accompanied by dizziness, rash, sometimes nausea, and weight loss of 3 kg. Routine blood test showed HGB 114 g/L, PLT 63×109/L, WBC 12.44×109/L, and immature cells 58%. The patient was hospitalized with acute leukemia in the Department of Hematology. Flow cytometry of bone marrow showed acute T-lymphocytic leukemia (T-ALL), and neck LN biopsy and skin biopsy showed involvement by tumor. The patient received chemotherapy with COPD regimen.

Figure 1.

Figure 1

(A) (H&E ×10) and (B) (H&E ×40). The epithelium was not markedly atypical and the stroma was filled with atypical lymphocytes. (C) CD34+ (×40). (D) TDT- (×40). (E) CD7+ (×40). (F) The positive rate of Ki67 was more than 60% (×40).

Discussion

WTs are benign neoplasms composed of a salivary gland epithelial component and lymphoid stroma, which arise from heterotopic salivary gland epithelium within intraparotid and periparotid LNs. Approximately 1% of WT transform to malignant tumors, which can occur either in the epithelial or the lymphoid components [1].

Cases of lymphoma and WT collision had been reported, most of which were Hodgkin’s lymphomas and B-cell-derived non-Hodgkin’s lymphomas (NHLs). Up to now, there have been 7 cases of Hodgkin’s lymphoma and 25 cases of B-cell lymphoma with clear classification in the English literature, of which follicular lymphoma (10 cases) was the major type [3-23].

However, there were only two reports on T-cell lymphoma in WT. One was about the T-LBL associated with WT in parotid gland and the other was peripheral T-cell lymphoma, NOS in WT of right cervical LNs (Table 1) [24,25]. The unusual TdT negative T-LBL occurring in heterotopic WT of neck, without signs of leukemia initially, made this case rare and interesting.

Table 1.

Summary of T-cell lymphoma in Warthin’s tumor

Author (year) Sex Age Site Mass size (cm) LDH (U/L) Diagnosis Stage before treatment Follow-up
Giaslakiotis (2009) [24] M 81 right parotid 5.8×4.7×4.0 2072 T-LBL IVB DOD, 3 months
Pescarmona (2005) [25] M 66 right cervical LN NA NA peripheral T-cell lymphoma, NOS IV DOD, 5 months
Present case F 69 left neck node 5*3*2 NA T-LBL IV DOD, 5 months
3*2*1.5

M, male; F, female; LN, lymph nodes; DOD, died of disease; NA, not available.

T-cell acute lymphoblastic leukemia/lymphoma (T-ALL/LBL) is an aggressive neoplasm derived from T-cell progenitors and TdT is the major marker for the confirmation of the precursor cell lymphoma. This rare case was diagnosed as TdT-LBL, because it showed the typical morphology of precursor cell neoplasms in addition to the expression of CD34 and T cell biomarkers. Cases of TDT-negative T-ALL/LBL are rare and patients have a significantly higher rate of disease progression and shorter overall survival [26]. The patient in this case progressed to acute leukemia in less than two months and died five months later because of poor response to chemotherapy, which was in line with the literature.

The pathogenesis of lymphoma and WT in combination is not clear and many factors might be involved in the pathogenesis, of which age and gender may play roles in tumorigenesis. Most reported cases of WT and lymphoma coexistence reported have happened in elderly males. Among 33 patients previously reported and our case, 5 were female and 28 were male, aged from 49 to 102 with the median age being 68 years and the average age being 71.28 years, so the disease is predominantly in elderly men [3-23].

In conclusion, this is the first case report that illustrates TdT-T-LBL arising from heterotopic Warthin’s tumor cervical lymph nodes and reminds us to examine the lymphatic stroma components of WT carefully.

Acknowledgements

This work was partly supported by Key R&D Project (Public Welfare Project) of Shandong Province (2017GSF218113) and Key R&D Project (Medical and Health) of Yantai (2017WS102).

The case report and any accompanying report pictures were signed with informed consent from the patient’s family members.

Disclosure of conflict of interest

None.

References

  • 1.Thompson L. World Health Organization classification of tumours: pathology and genetics of head and neck tumours. Ear Nose Throat J. 2006;85:74. [PubMed] [Google Scholar]
  • 2.Ferlito A, Bertino G, Rinaldo A, Mannara GM, Devaney KO. A review of heterotopia and associated salivary gland neoplasms of the head and neck. J Laryngol Otol. 1999;113:299–303. doi: 10.1017/s0022215100143841. [DOI] [PubMed] [Google Scholar]
  • 3.Arcega RS, Feinstein AJ, Bhuta S, Blackwell KE, Rao NP, Pullarkat ST. An unusual initial presentation of mantle cell lymphoma arising from the lymphoid stroma of warthin tumor. Diagn Pathol. 2015;10:209. doi: 10.1186/s13000-015-0444-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Chu CY, Pan SC, Chang KC. EBV-positive diffuse large B-cell lymphoma of the elderly involving Warthin tumor. Pathol Int. 2015;65:677–9. doi: 10.1111/pin.12325. [DOI] [PubMed] [Google Scholar]
  • 5.Jawad H, McCarthy P, O’Leary G, Heffron CC. Presentation of chronic lymphocytic leukemia/small lymphocytic lymphoma in a warthin tumor: case report and literature review. Int J Surg Pathol. 2018;26:256–260. doi: 10.1177/1066896917734371. [DOI] [PubMed] [Google Scholar]
  • 6.Jun L, Ming Z. Classical Hodgkin lymphoma arising from heterotopic Warthin’s tumor in the cervical lymph node: a case report. Oncol Lett. 2018;16:619–622. doi: 10.3892/ol.2018.8682. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Liu YQ, Tang QL, Wang LL, Liu QY, Fan S, Li HG. Concomitant lymphocyte-rich classical Hodgkin’s lymphoma and Warthin’s tumor. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;116:e117–20. doi: 10.1016/j.oooo.2013.05.004. [DOI] [PubMed] [Google Scholar]
  • 8.Ozkok G, Tasli F, Ozsan N, Ozturk R, Postaci H. Diffuse large B-cell lymphoma arising in warthin’s tumor: case study and review of the literature. Korean J Pathol. 2013;47:579–82. doi: 10.4132/KoreanJPathol.2013.47.6.579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Saxena A, Memauri B, Hasegawa W. Initial diagnosis of small lymphocytic lymphoma in parotidectomy for Warthin tumour, a rare collision tumour. J Clin Pathol. 2005;58:331–3. doi: 10.1136/jcp.2004.019760. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Song K, Cotelingam JD, Lowery-Nordberg M, Sun W. Characterization of the lymphoid stroma in Warthin’s tumor of salivary gland by immunohistochemistry, heavy chain gene and Bcl-2 gene rearrangement. Am J Transl Res. 2009;1:352–7. [PMC free article] [PubMed] [Google Scholar]
  • 11.Badve S, Evans G, Mady S, Coppen M, Sloane J. A case of Warthin’s tumour with coexistent Hodgkin’s disease. Histopathology. 1993;22:280–1. doi: 10.1111/j.1365-2559.1993.tb00121.x. [DOI] [PubMed] [Google Scholar]
  • 12.Griesser GH, Hansmann ML, Bogman MJ, Pielsticker K, Lennert K. Germinal center derived malignant lymphoma in cystadenolymphoma. Virchows Arch A Pathol Anat Histopathol. 1986;408:491–6. doi: 10.1007/BF00705302. [DOI] [PubMed] [Google Scholar]
  • 13.Romero M, Gonzalez-Fontal GR, Duarte M, Saavedra C, Henao-Martinez AF. Small clonal B-cell population in the bone marrow as a possible tool in the diagnosis of occult primary parotid lymphoma. Colomb Med (Cali) 2016;47:59–62. [PMC free article] [PubMed] [Google Scholar]
  • 14.Medeiros LJ, Rizzi R, Lardelli P, Jaffe ES. Malignant lymphoma involving a Warthin’s tumor: a case with immunophenotypic and gene rearrangement analysis. Hum Pathol. 1990;21:974–7. doi: 10.1016/0046-8177(90)90182-5. [DOI] [PubMed] [Google Scholar]
  • 15.Park CK, Manning JT Jr, Battifora H, Medeiros LJ. Follicle center lymphoma and Warthin tumor involving the same anatomic site. Report of two cases and review of the literature. Am J Clin Pathol. 2000;113:113–9. doi: 10.1309/MJH0-RQGX-U128-VFC6. [DOI] [PubMed] [Google Scholar]
  • 16.Marioni G, Marchese-Ragona R, Marino F, Poletti A, Ottaviano G, de Filippis C, Staffieri A. MALT-type lymphoma and Warthin’s tumour presenting in the same parotid gland. Acta Otolaryngol. 2004;124:318–23. doi: 10.1080/00016480310015263. [DOI] [PubMed] [Google Scholar]
  • 17.Miller R, Yanagihara ET, Dubrow AA, Lukes RJ. Malignant lymphoma in the Warthin’s tumor. Report of a case. Cancer. 1982;50:2948–50. doi: 10.1002/1097-0142(19821215)50:12<2948::aid-cncr2820501240>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  • 18.Rashidi A, Fisher SI. Double-hit lymphoma mimicking acute lymphoblastic leukemia at presentation. Eur J Haematol. 2015;94:374–6. doi: 10.1111/ejh.12397. [DOI] [PubMed] [Google Scholar]
  • 19.Melato M, Falconieri G, Fanin R, Baccarani M. Hodgkin’s disease occurring in a Warthin’s tumor: first case report. Pathol Res Pract. 1986;181:615–20. doi: 10.1016/S0344-0338(86)80158-3. [DOI] [PubMed] [Google Scholar]
  • 20.Giardini R, Mastore M. Follicular non Hodgkin’s lymphoma in adenolymphoma: report of a case. Tumori. 1990;76:212–5. doi: 10.1177/030089169007600212. [DOI] [PubMed] [Google Scholar]
  • 21.Shikhani AH, Shikhani LT, Kuhajda FP, Allam CK. Warthin’s tumor-associated neoplasms: report of two cases and review of the literature. Ear Nose Throat J. 1993;72:264–9. 272–3. [PubMed] [Google Scholar]
  • 22.Bunker ML, Locker J. Warthin’s tumor with malignant lymphoma. DNA analysis of paraffin-embedded tissue. Am J Clin Pathol. 1989;91:341–4. doi: 10.1093/ajcp/91.3.341. [DOI] [PubMed] [Google Scholar]
  • 23.Reiner M, Goldhirsch A, Luscieti PR, Pedrinis E, Kaplan E, Cavalli F. Warthin’s tumor with Sjogren’s syndrome and non-Hodgkin’s lymphoma. Ear Nose Throat J. 1979;58:345–50. [PubMed] [Google Scholar]
  • 24.Giaslakiotis K, Androulaki A, Panagoulias G, Kyrtsonis MC, Lazaris AC, Kanakis DN, Patsouris ES. T cell lymphoblastic lymphoma in parotidectomy for Warthin’s tumor: case report and review of the literature. Int J Hematol. 2009;89:359–364. doi: 10.1007/s12185-009-0271-z. [DOI] [PubMed] [Google Scholar]
  • 25.Pescarmona E, Perez M, Faraggiana T, Granati L, Baroni CD. Nodal peripheral T-cell lymphoma associated with Warthin’s tumour. Histopathology. 2005;47:221–2. doi: 10.1111/j.1365-2559.2005.02079.x. [DOI] [PubMed] [Google Scholar]
  • 26.Zhou Y, Fan X, Routbort M, Cameron Yin C, Singh R, Bueso-Ramos C, Thomas DA, Milton DR, Medeiros LJ, Lin P. Absence of terminal deoxynucleotidyl transferase expression identifies a subset of high-risk adult T-lymphoblastic leukemia/lymphoma. Mod Pathol. 2013;26:1338–45. doi: 10.1038/modpathol.2013.78. [DOI] [PubMed] [Google Scholar]

Articles from International Journal of Clinical and Experimental Pathology are provided here courtesy of e-Century Publishing Corporation

RESOURCES